
Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
AZN | London | GBP | Real-time | |
3LAZ | London | GBP | Real-time | |
3SAZ | London | GBP | Real-time | |
AZNl | BATS Europe | GBP | Delayed | |
AZNs | BATS Europe | SEK | Delayed | |
AZN | NASDAQ | USD | Real-time | |
AZNCF | OTC Markets | USD | Delayed | |
AZNN | Mexico | MXN | Delayed | |
AZN | Stockholm | SEK | Real-time | |
AZN | Frankfurt | EUR | Delayed | |
AZN | TradeGate | EUR | Delayed | |
AZN | Xetra | EUR | Delayed | |
AZNPy | Frankfurt | EUR | Delayed | |
AZN | Buenos Aires | ARS | Delayed |
AstraZeneca PLC (AstraZeneca) is a patient-focused biopharmaceutical company. The Company focuses on discovery and development, manufacturing and commercialization of prescription medicines, primarily for the treatment of diseases. The Company is focused on three main therapy areas: Oncology; Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Its pipeline forms a robust portfolio of investigational therapies in varied stages of clinical development. The Company has access to technologies, both internally and through its various collaborations. Its technologies include acoustic tube technology, advanced molecular imaging, cryo-electron microscopy (cryo-EM), functional genomics, multi-omics and AstraZeneca iLab. The Company’s acoustic tube technology helps it to handle and process millions of compounds for biological screening. Its AstraZeneca iLab is its prototype of an automated medicinal chemistry laboratory.
Name | Age | Since | Title |
---|---|---|---|
Euan A. Ashley | 49 | 2020 | Independent Non-Executive Director |
Diana Layfield | 50 | 2020 | Independent Non-Executive Director |
Marcus Wallenberg | 66 | 1999 | Non-Executive Director |
Leif Johansson | 70 | 2012 | Independent Non-Executive Chairman |
Pascal Soriot | 62 | 2012 | CEO & Executive Director |
Nazneen Rahman | 53 | 2017 | Independent Non-Executive Director |
Deborah DiSanzo Eldracher | 61 | 2017 | Independent Non-Executive Director |
Shu Kam Mok | 60 | 2019 | Independent Non-Executive Director |
Sherilyn S. D. McCoy | 62 | 2017 | Independent Non-Executive Director |
Philip Arthur John Broadley | 60 | 2017 | Senior Independent Non-Executive Director |
Michel Demare | 65 | 2019 | Independent Non-Executive Director |
Jeffrey Pott | - | 2009 | EVP of HR, Chief HR Officer, General Counsel & Member of External Sustainability Advisory Board |
Katarina Ageborg | - | 2011 | EVP of Sustainability, Chief Compliance Officer & Member of External Sustainability Advisory Board |
Pam P. Cheng | 50 | 2015 | EVP of Operations & Information Technology and Member of External Sustainability Advisory Board |
Polly Courtice | 69 | - | Member of External Sustainability Advisory Board |
Rain Henderson | - | - | Member of External Sustainability Advisory Board |
Pankaj Bhatia | - | - | Member of External Sustainability Advisory Board |
Louise Nicholls | - | - | Member of External Sustainability Advisory Board |
Andreas Rummelt | 66 | 2021 | Independent Non-Executive Director |
Aradhana Sarin | 47 | 2021 | CFO & Executive Director |
Menelas Pangalos | - | 2013 | EVP of BioPharmaceuticals R&D and Member of External Sustainability Advisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review